Appointments

Anglo American Position: Non Executive Director
Holding Balance: 24,510, appointed in 2009

All Deals

Declared Dealt Type EPIC Company Director Pos Shares Price Value Cur. price % Gain Gain Notes
24/07/19 24/07/19 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,645 1,654.00p £43,748.00 1,344.80p -18.69 -£8,178.04
01/05/19 01/05/19 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,790 1,568.00p £43,747.00 1,344.80p -14.23 -£6,227.08
06/02/19 06/02/19 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,926 1,495.00p £43,744.00 1,344.80p -10.05 -£4,395.15
20/12/18 19/12/18 LOF AAL Anglo American PLC Hampton, Philip NED 617 1,731.40p £10,683.00 1,954.80p
02/11/18 31/10/18 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,867 1,526.00p £43,750.00 1,344.80p -11.87 -£5,194.58
01/10/18 27/09/18 LOF AAL Anglo American PLC Hampton, Philip NED 594 1,723.20p £10,236.00 1,954.80p
25/07/18 25/07/18 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,810 1,557.00p £43,752.00 1,344.80p -13.63 -£5,963.12
26/06/18 25/06/18 LOF AAL Anglo American PLC Hampton, Philip NED 512 1,659.40p £8,496.00 1,954.80p
26/04/18 25/04/18 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 3,028 1,445.00p £43,755.00 1,344.80p -6.93 -£3,034.46
26/04/18 25/04/18 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 3,028 1,445.00p £43,755.00 1,344.80p -6.93 -£3,034.46
29/03/18 28/03/18 LOF AAL Anglo American PLC Hampton, Philip NED 603 1,635.40p £9,861.00 1,954.80p
07/02/18 07/02/18 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 3,423 1,278.00p £43,746.00 1,344.80p 5.23 £2,286.50
21/12/17 20/12/17 LOF AAL Anglo American PLC Hampton, Philip NED 666 1,478.00p £9,843.00 1,954.80p
25/10/17 25/10/17 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,882 1,518.00p £43,749.00 1,344.80p -11.41 -£4,991.86
27/09/17 26/09/17 LOF AAL Anglo American PLC Hampton, Philip NED 725 1,289.00p £9,345.00 1,954.80p
26/07/17 26/07/17 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,736 1,599.00p £43,749.00 1,344.80p -15.90 -£6,955.27
26/06/17 26/06/17 LOF AAL Anglo American PLC Hampton, Philip NED 808 982.00p £7,935.00 1,954.80p
27/04/17 26/04/17 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 2,764 1,583.00p £43,754.00 1,344.80p -15.05 -£6,583.73
27/03/17 24/03/17 LOF AAL Anglo American PLC Hampton, Philip NED 727 1,264.00p £9,189.00 1,954.80p
09/02/17 08/02/17 BUY GSK Glaxosmithkline PLC Hampton, Philip RES 924 1,555.00p £14,368.00 1,344.80p -13.52 -£1,942.05
Showing 1 to 20 of 57

Transaction types:

  • BUY - Buy
  • SELL - Sell
  • EXR - Exercise
  • SEXR - Sale Post-Exercise
  • DRI - Dividend Reinvestment
  • DRIP - Dividend Reinvestment Plan
  • AWD - Award
  • TIN - Transfer In
  • TOUT - Transfer Out
  • LOF - In Lieu of Fees/Salary
  • SI - Scrip Issue
  • PLAC - Placing
  • RIS - Rights Issue

Director positions:

  • CEO - Chief Executive Officer
  • CH - Chairman
  • MD - Managing Director
  • FD - Financial Director
  • NED - Non Executive Director
  • ED - Executive Director
  • RES - Resigned
  • D - Director / Unknown